Mechanism of Action.
GHK-Cu is a naturally occurring tripeptide (Gly-His-Lys) with a strong affinity for copper(II) ions. It is found in human plasma at approximately 200 ng/mL in youth, declining to approximately 80 ng/mL by age 60. The peptide-copper complex activates multiple regenerative pathways: it stimulates collagen I, III, and IV synthesis, promotes decorin and glycosaminoglycan production, increases angiogenesis through VEGF and FGF-2 upregulation, and attracts immune cells to wound sites. At the genomic level, GHK-Cu has been shown to modulate the expression of over 4,000 human genes, generally shifting expression patterns from a damaged or aged state toward a healthier baseline. It also acts as a potent antioxidant by increasing superoxide dismutase (SOD) and inhibiting iron-mediated lipid peroxidation.
Research Summary.
GHK-Cu has decades of research supporting its wound healing and tissue remodeling properties. Studies show it accelerates wound contraction, increases granulation tissue formation, and enhances tensile strength of healed tissue. In skin research, GHK-Cu has demonstrated improvements in skin thickness, elasticity, and wrinkle reduction. Research extends beyond dermatology: GHK-Cu has shown anti-inflammatory activity by suppressing TGF-beta-driven fibrosis, neuroprotective effects in models of oxidative brain damage, and potential anti-cancer activity through modulation of tissue remodeling genes. A comprehensive gene expression analysis found GHK-Cu upregulates DNA repair genes, anti-cancer protective genes, and antioxidant genes while downregulating pro-inflammatory and tissue-destructive gene sets.
Side Effects & Safety.
GHK-Cu is an endogenous peptide with a well-established safety profile. As a naturally occurring compound in human plasma, it is generally well-tolerated. Topical formulations have been widely used in cosmetics with minimal adverse effects. Injection site reactions (mild redness, irritation) may occur with subcutaneous administration. Copper toxicity is a theoretical concern with excessive dosing, though the amounts of copper delivered by GHK-Cu supplementation are far below toxic thresholds. Individuals with Wilson disease or other copper metabolism disorders should exercise caution.
Legal Status & Access.
GHK-Cu is classified as a Category 1 research peptide for injectable formulations. Topical GHK-Cu is widely available in cosmetic and skincare products. Injectable research-grade GHK-Cu is available from peptide suppliers for laboratory investigation.